loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Technical details about Danoprevir, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Danoprevir, 850876-88-9, Schembl2833159, Zinc150357979, Cs-0337, Ac-32903
Molecular Formula
C35H46FN5O9S
Molecular Weight
731.8  g/mol
InChI Key
ZVTDLPBHTSMEJZ-AIYSODCISA-N

Danoprevir is an orally bioavailable, peptidomimetic inhibitor of hepatitis C virus (HCV) NS3/4A protease, with antiviral activity against HCV and potential antiviral activity against SARS-CoV-2. Upon oral administration, danoprevir binds to and blocks the activity of HCV NS3/4A protease. This prevents the cleavage and processing of HCV viral proteins leading to the inhibition of HCV replication. Danoprevir may also bind to and block of the activity of SARS-CoV-2 protease. This prevents the cleavage and processing of SARS-CoV-2 viral proteins leading to the inhibition of SARS-CoV-2 replication. NS3/4A, a chymotrypsin-like serine protease, is responsible for cleavage at four sites of the HCV polyprotein to form the viral proteins required for HCV replication. It plays a key role in the HCV viral replication process. HCV infection is associated with the development of hepatocellular carcinoma (HCC). A chymotrypsin-like protease is responsible for cleavage of the SARS-CoV-2 viral polyprotein to form the RNA replicase-transcriptase complex, which plays a key role in the SARS-CoV-2 viral transcription and replication process.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(1S,4R,6S,7E,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate
2.1.2 InChI
InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7+/t22-,23-,27+,28+,35-/m1/s1
2.1.3 InChI Key
ZVTDLPBHTSMEJZ-AIYSODCISA-N
2.1.4 Canonical SMILES
CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6
2.1.5 Isomeric SMILES
CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Danoprevir

2. Itmn 191

3. Itmn-191

4. Itmn191

5. R 7227

6. R-7227

7. R7227 Cpd

8. Rg 7227

9. Rg-7227

10. Rg7227

2.2.2 Depositor-Supplied Synonyms

1. Danoprevir

2. 850876-88-9

3. Schembl2833159

4. Zinc150357979

5. Cs-0337

6. Ac-32903

7. Hy-10238

8. 2h-isoindole-2-carboxylic Acid, 4-fluoro-1,3-dihydro-, (2r,6s,13as,14ar,16as)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl Ester

2.3 Create Date
2011-11-16
3 Chemical and Physical Properties
Molecular Weight 731.8 g/mol
Molecular Formula C35H46FN5O9S
XLogP33.3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count10
Rotatable Bond Count8
Exact Mass731.30002740 g/mol
Monoisotopic Mass731.30002740 g/mol
Topological Polar Surface Area189 Ų
Heavy Atom Count51
Formal Charge0
Complexity1530
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY